ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/050/SRR18531150/SRR18531150_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/044/SRR18531144/SRR18531144_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/046/SRR18531146/SRR18531146_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/048/SRR18531148/SRR18531148_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/043/SRR18531143/SRR18531143_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/046/SRR18531146/SRR18531146_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/044/SRR18531144/SRR18531144_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/047/SRR18531147/SRR18531147_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/049/SRR18531149/SRR18531149_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/050/SRR18531150/SRR18531150_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/043/SRR18531143/SRR18531143_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/051/SRR18531151/SRR18531151_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/047/SRR18531147/SRR18531147_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/049/SRR18531149/SRR18531149_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/045/SRR18531145/SRR18531145_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/051/SRR18531151/SRR18531151_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/045/SRR18531145/SRR18531145_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR185/048/SRR18531148/SRR18531148_2.fastq.gzprimary200OKGenomicsTri-Service General Hospitalhttps://www.ebi.ac.uk/ena/browser/view/PRJNA821327The trial used CDNF to treat BV2 microglia cell damaged by 6-OHDA.xref:EuropePMC:PMC9221078ENAMicroglial, MF.microglia.CNS, microglial cell, 9330140G23, Armetl1., Hortega cell, Microglial Cell, brain-resident macrophage, ARMETL1, brain macrophage, hortega cells, Microglias, microgliocyte, Microglial Cells, microglia, CellfalseBV2 microglial cell + 6-OHDA + CDNF2023-05-192022-04-01PRJNA821327